The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
Abstract
The prevalence of apparent amiodarone-related hepatic injury in 104 patients followed prospectively is compared to that reported in the literature. Asymptomatic elevation of serum aminotransferase levels was detected in approximately one-fourth of the patients, a figure similar to the average of reported cases. The frequency of extrahepatic organ toxicity was increased in patients with elevated levels. Symptomatic “hepatitis” developed in 3% of this series and in less than 1% of cases in the litérature. Evidence of hepatic phospholipidosis and the development of pseudoalcoholic liver injury is most likely due to the biochemical effects of the drug and to possible metabolic idiosyncrasy, respectively. Serial blood enzyme measurements, as recommended by the manufacturer, may offer some protection against the development of more serious liver injury. However, levels of amiodarone may persist in various tissues for weeks to months following withdrawal, and stopping the drug does not guarantee the prompt reversal of any organ toxicity. Accordingly, the risks posed and benefits offered by amiodarone should be carefully weighed prior to discontinuing the drug, as the risk of sudden cardiac death may outweigh the hazards of ongoing hepatic, pulmonary or other toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatotoxicity. The adverse effects of drugs and other chemicals on the liver
(1980) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(80)90206-0 · Cited by 691
Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver
Maddrey, W. C. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70192-2 · Cited by 646
Heger, J. J., Prystowsky, E. N., Jackman, W. M., Naccarelli, G. V., Warfel, K. A., Rinkenberger, R. L., & Zipes, D. P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198109033051002 · Cited by 571
Oates, J. A., Wood, A. J. J., & Mason, J. W. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702193160807 · Cited by 412
Holt, D. W., Tucker, G. T., Jackson, P. R., & Storey, G. C. A. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90006-6 · Cited by 410
Burger, A., Dinichert, D., Nicod, P., Jenny, M., Lemarchand-Béraud, T., & Vallotton, M. B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108466 · Cited by 312
MARCHLINSKI, F. E., GANSLER, T. S., WAXMAN, H. L., & JOSEPHSON, M. E. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-6-839 · Cited by 311
Lüllmann, H., Lüllmann-Rauch, R., Wassermann, O., & de la Iglesia, F. A. (1975) · CRC Critical Reviews in Toxicology · doi:10.1080/10408447509164014 · Cited by 291
Waxman, H. L., Groh, W. C., Marchlinski, F. E., Buxton, A. E., Sadowski, L. M., Horowitz, L. N., Josephson, M. E., & Kastor, J. A. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90419-2 · Cited by 249
Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
Haffajee, C. I., Love, J. C., Canada, A. T., Lesko, L. J., Asdourian, G., & Alpert, J. S. (1983) · Circulation · doi:10.1161/01.cir.67.6.1347 · Cited by 240
Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias
Greene, H. L., Graham, E. L., Werner, J. A., Sears, G. K., Gross, B. W., Gorham, J. P., Kudenchuk, P. J., & Trobaugh, G. B. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80338-6 · Cited by 238
Side effects and complications of amiodarone therapy
Raeder, E. A., Podrid, P. J., & Lown, B. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90238-8 · Cited by 216
Amiodarone Hepatotoxicity Simulating Alcoholic Liver Disease
Simon, J. B., Manley, P. N., Brien, J. F., & Armstrong, P. W. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407193110308 · Cited by 182
Poucell, S., Ireton, J., Valencia‐Mayoral, P., Downar, E., Larratt, L. M., Patterson, J., Blendis, L. M., & Phillips, M. J. (1984) · PubMed · Cited by 177
Impaired oxidation of debrisoquine in patients with perhexiline liver injury.
Morgan, M. Y., Reshef, R., Shah, R. R., Oates, N. S., Smith, R. L., & Sherlock, S. (1984) · Gut · doi:10.1136/gut.25.10.1057 · Cited by 163
Richman, S. M., Delman, A. J., & Grob, D. (1961) · The American Journal of Medicine · doi:10.1016/0002-9343(61)90093-6 · Cited by 132
Frequent neurologic toxicity associated with amiodarone therapy
Charness, M. E., Morady, F., & Scheinman, M. M. (1984) · Neurology · doi:10.1212/wnl.34.5.669 · Cited by 116
Amiodarone-induced Phospholipidosis in Rat Alveolar Macrophages
Reasor, M. J., Ogle, C. L., Walker, E. R., & Kacew, S. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.3.510 · Cited by 88
Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats
Hostetler, K. Y., Reasor, M. J., Walker, E. R., Yazaki, P. J., & Frazee, B. W. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90192-x · Cited by 87
Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity
St�ubli, M., Bircher, J., Galeazzi, R. L., Remund, H., & Studer, H. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00609891 · Cited by 87
Rigas, B., ROSENFELD, L. E., BARWICK, K. W., ENRIQUEZ, R., HELZBERG, J., BATSFORD, W. P., Josephson, M. E., & RIELY, C. A. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-3-348 · Cited by 84
Heath, M. F., Costa‐Jussà, F. R., Jacobs, J. M., & Jacobson, W. (1985) · PubMed Central · Cited by 80
Shaikh, N., Downar, E. H., & BUTANY, J. W. (1987) · Molecular and Cellular Biochemistry · doi:10.1007/bf00223481 · Cited by 75
Increased hepatic density and phospholipidosis due to amiodarone
Goldman, I. S., Winkler, M. L., Raper, S. E., Barker, M., Keung, E., Goldberg, H., & Td, B. (1985) · American Journal of Roentgenology · doi:10.2214/ajr.144.3.541 · Cited by 66
Nademanee, K., Singh, B. N., Callahan, B. L., Hendrickson, J. A., & Hershman, J. M. (1986) · The American Journal of Cardiology · doi:10.1016/s0002-9149(86)80023-6 · Cited by 62
Long-term tolerance of amiodarone treatment for cardiac arrhythmias
Smith, W., Lubbe, W. F., Whitlock, R. M. L., Mercer, J., Rutherford, J. D., & Roche, A. H. G. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90206-7 · Cited by 53
Chronic liver disease after low daily doses of amiodarone
Babany, G., Mallat, A., Zafrani, É. S., Girardin, M. F. S.-M., Carcone, B., & Dhumeaux, D. (1986) · Journal of Hepatology · doi:10.1016/s0168-8278(86)80031-9 · Cited by 40
Falik, R., Flores, B. T., Shaw, L. M. J., Gibson, G. A., Josephson, M. E., & Marchlinski, F. E. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90211-7 · Cited by 40
Pirovino, M., Müller, O. M., Zysset, T., & Honegger, U. (1988) · Hepatology · doi:10.1002/hep.1840080326 · Cited by 39
Value of hepatic computerized tomographic scanning during amiodarone therapy
Markos, J., Veronese, M. E., Nicholson, M. R., McLean, S., & Shevland, J. E. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90572-7 · Cited by 31
Fatal hepatic failure and encephalopathy associated with amiodarone therapy
Yagupsky, P., Gazala, E., Sofer, S., Maor, E., & Abarbanel, J. M. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80206-7 · Cited by 30
Pneumonitis after amiodarone therapy.
Olson, L. K., Forrest, J. V., Friedman, P. J., et al. (1984) · Radiology · doi:10.1148/radiology.150.2.6691083 · Cited by 24
Cited by
Rinella, M. E., Neuschwander-Tetri, B. A., Siddiqui, M. S., Abdelmalek, M. F., Caldwell, S., Barb, D., Kleiner, D. E., & Loomba, R. (2023) · Hepatology · doi:10.1097/hep.0000000000000323 · Cited by 2,667
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Metadata
- Authors
- Lewis, J. H., Ranard, R. C., Caruso, A., Jackson, L. K., Mullick, F., Ishak, K. G., Seeff, L. B., & Zimmerman, H. J.
- Venue
- Hepatology
- Published
- 1989-05
- Volume
- 9
- Issue
- 5
- Pages
- 679-685
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1964153329
- Cited by
- 266
- References
- 32
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.